Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$468M |
| 2 |
Johnson & Johnson
JNJ
|
+$440M |
| 3 |
IBM
IBM
|
+$355M |
| 4 |
Booking.com
BKNG
|
+$332M |
| 5 |
RAI
Reynolds American Inc
RAI
|
+$331M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LLTC
Linear Technology Corp
LLTC
|
+$482M |
| 2 |
Walt Disney
DIS
|
+$247M |
| 3 |
Visa
V
|
+$219M |
| 4 |
Deere & Co
DE
|
+$200M |
| 5 |
Johnson Controls International
JCI
|
+$179M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.02% |
| 2 | Technology | 13.31% |
| 3 | Financials | 12.25% |
| 4 | Industrials | 9.65% |
| 5 | Consumer Staples | 9.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
951
Ulta Beauty
ULTA
$22.9B
| $15.7M | 0.02% |
55,202
+13,302
| +32% | +$3.64M |
|
|
NXRT
952
NexPoint Residential Trust
NXRT
$631M
| $15.7M | 0.02% |
651,100
+152,600
| +31% | +$3.57M |
|
|
WMGI
953
DELISTED
Wright Medical Group Inc
WMGI
| $15.7M | 0.02% |
+504,107
| New | +$13.7M |
|
|
FARM
954
DELISTED
Farmer Brothers
FARM
| $15.7M | 0.02% |
443,200
+5,000
| +1% | +$168K |
|
|
NCI
955
DELISTED
Navigant Consulting, Inc.
NCI
| $15.7M | 0.02% |
684,700
+41,200
| +6% | +$983K |
|
956
Adobe
ADBE
$103B
| $15.6M | 0.02% |
120,100
-165,333
| -58% | -$19.4M |
|
957
Williams Companies
WMB
$90.1B
| $15.6M | 0.02% |
528,000
-1,847,100
| -78% | -$53.4M |
|
958
Camden National
CAC
$990M
| $15.6M | 0.02% |
354,449
+25,749
| +8% | +$1.09M |
|
|
BID
959
DELISTED
Sotheby's
BID
| $15.6M | 0.02% |
343,203
+179,703
| +110% | +$7.69M |
|
960
D.R. Horton
DHI
$40.8B
| $15.6M | 0.02% |
467,438
-3,103,400
| -87% | -$96.3M |
|
|
CSFL
961
DELISTED
CenterState Bank Corporation Common Stock
CSFL
| $15.5M | 0.02% |
597,700
+46,700
| +8% | +$1.17M |
|
962
State Street Financial Select Sector SPDR ETF
XLF
$59.1B
| $15.5M | 0.02% |
+652,000
| New | +$15.6M |
|
963
Oil-Dri
ODC
$1.28B
| $15.4M | 0.02% |
827,450
-14,096
| -2% | -$248K |
|
964
Brunswick
BC
$5.21B
| $15.4M | 0.02% |
251,500
-77,100
| -23% | -$4.56M |
|
965
Ducommun
DCO
$3.04B
| $15.3M | 0.02% |
533,100
-25,300
| -5% | -$737K |
|
966
Ingredion
INGR
$6.54B
| $15.3M | 0.02% |
127,400
+9,100
| +8% | +$1.11M |
|
|
DHIL
967
DELISTED
Diamond Hill
DHIL
| $15.3M | 0.02% |
78,800
-300
| -0.4% | -$60K |
|
968
WesBanco
WSBC
$4.07B
| $15.3M | 0.02% |
401,742
+67,069
| +20% | +$2.71M |
|
969
Willdan Group
WLDN
$1.29B
| $15.3M | 0.02% |
472,716
-34,273
| -7% | -$977K |
|
970
Winmark
WINA
$1.24B
| $15.2M | 0.02% |
134,300
+4,200
| +3% | +$481K |
|
|
PFC
971
DELISTED
Premier Financial Corp. Common Stock
PFC
| $15.2M | 0.02% |
613,000
+42,610
| +7% | +$1.05M |
|
972
Belden
BDC
$5.39B
| $15.2M | 0.02% |
219,075
+179,675
| +456% | +$13.2M |
|
|
VSA
973
VisionSys AI
VSA
$10.3M
| $15.2M | 0.02% |
325
+182
| +127% | +$7.32M |
|
974
BGC Group
BGC
$5.12B
| $15.1M | 0.02% |
2,072,268
+1,275,411
| +160% | +$9.17M |
|
|
DHC
975
Diversified Healthcare Trust
DHC
$2.02B
| $15.1M | 0.02% |
746,400
-109,900
| -13% | -$2.15M |
|
Similar funds
Jim Simons's Q1 2017 Portfolio in Review
As of Q1 2017, Jim Simons held 3,652 positions worth $71.6B, up 13% from $63.2B the previous quarter. Its ten largest holdings account for 7.9% of the portfolio.
Jim Simons deployed $5.19B of net new capital in Q1 2017, opening 433 new positions and adding to 1,585 existing holdings. Its largest new stake was Merck: 7,716,460 shares worth $468M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 12% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Walt Disney, an estimated $247M trimmed.
- Jim Simons's largest Q1 2017 buy was Merck: 7,716,460 shares worth $468M.
- Jim Simons added most to Johnson & Johnson in Q1 2017, an estimated $440M increase.
- Jim Simons's biggest Q1 2017 reduction was Walt Disney, cutting an estimated $247M.
- Jim Simons fully exited Linear Technology Corp in Q1 2017, selling an estimated $482M.
- Jim Simons's ten largest holdings make up 7.9% of its $71.6B portfolio in Q1 2017.
- Jim Simons opened 433 new positions and closed 462 in Q1 2017.
- Jim Simons's portfolio value rose 13% quarter-over-quarter to $71.6B.
Based on Renaissance Technologies's 13F filing for Q1 2017, filed 12 May 2017.